PCI - Triangle forming possible break outBullish case
- PCI breaking out of its tri
- Parent index breaking out of Asc Tri
- Parent index in strong relative strength
- Bio tech ETF are breaking out on relative strong strength
- Dead cat bounce potential here
- Can spike to targets quickly
Disclaimer not advice, only for educational purp
−0.440 NOK
−16.42 M NOK
0.00 NOK
26.31 M
About PCI BIOTECH HOLDING ASA
Sector
Industry
CEO
Ronny Skuggedal
Website
Headquarters
Oslo
Founded
2007
ISIN
NO0010405640
FIGI
BBG000V2X8P9
PCI Biotech Holding ASA engages in the research and development of biopharmaceutical products for cancer treatment. Its photochemical internalization technology therapy enhances the effect of anticancer drugs on the body. The company was founded in 2000 and is headquartered in Oslo, Norway.
No news here
Looks like there's nothing to report right now
PCI Biotech $PCIB bullish breaching 100EMA coming into Q4* Norwegian Drug Delivery Platform Biotech operating within the Oslo Cancer Cluster
* Notoriously volatile norwegian small cap with large amount of stock held by enthusiastic retail investor crowd.
* Ongoing research collaboration with AstraZeneca recently concluded, longs betting on partnership dea
OLong

Target 51,- this week? Just broke up from a descending triangle. Met resistance at second previous high at 49,4
If we in the next few days manage to establish above 49,4, the 51,5 resistance should be easy to take out.
OLong

OShort

OLong

American cancer vaccine patent boost $PCIB.OL over falling wedgePCI Biotech: US patent granted for the vaccine technology (fimaVACC) in combination with cytokines
Oslo (Norway), 21 January 2020 – PCI Biotech OSL:PCIB , a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has granted the company a US pat
PCI Biotech $PCIB.OL top 10 hot nordic stocks @veckansaffarer
www.va.se
finansavisen.no
PCI Biotech OSL:PCIB is a biopharmaceutical company focusing on development and commercialisation of novel therapeutic solutions for improved treatment of cancer patients through its innovative photochemical internalisation (PCI) technology platform. PCI ind
OLong

See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PCIB is 1.760 NOK — it has decreased by −5.38% in the past 24 hours. Watch PCI BIOTECH HOLDING ASA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange PCI BIOTECH HOLDING ASA stocks are traded under the ticker PCIB.
PCIB stock has risen by 11.75% compared to the previous week, the month change is a 32.83% rise, over the last year PCI BIOTECH HOLDING ASA has showed a −6.68% decrease.
PCIB reached its all-time high on Jun 24, 2020 with the price of 87.400 NOK, and its all-time low was 1.100 NOK and was reached on Nov 12, 2024. View more price dynamics on PCIB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PCIB stock is 12.50% volatile and has beta coefficient of 0.23. Track PCI BIOTECH HOLDING ASA stock price on the chart and check out the list of the most volatile stocks — is PCI BIOTECH HOLDING ASA there?
Today PCI BIOTECH HOLDING ASA has the market capitalization of 65.69 M, it has increased by 35.03% over the last week.
Yes, you can track PCI BIOTECH HOLDING ASA financials in yearly and quarterly reports right on TradingView.
PCIB net income for the last half-year is −9.02 M NOK, while the previous report showed −7.40 M NOK of net income which accounts for −21.79% change. Track more PCI BIOTECH HOLDING ASA financial stats to get the full picture.
No, PCIB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 19, 2025, the company has 5 employees. See our rating of the largest employees — is PCI BIOTECH HOLDING ASA on this list?
Like other stocks, PCIB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PCI BIOTECH HOLDING ASA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PCI BIOTECH HOLDING ASA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PCI BIOTECH HOLDING ASA stock shows the sell signal. See more of PCI BIOTECH HOLDING ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.